A survey of medical literature was carried out to identify clinical trials, systematic reviews or meta-analyses, practice guidelines and adverse drug reaction reports relevant to the clinical use of ether as anaesthetic. A remarkable paucity of recent literature was noted.
Introduction
Ether (diethyl ether) is an inhalational general anaesthetic agent listed in the 2004 WHO Model Formulary for induction and maintenance of general anaesthesia in adults and children. 1 It is a potent anaesthetic that made modern surgery possible. A second and related product listed in the Formulary is the halogenated anaesthetic halothane. This is more stable and safer to use than ether, and offers more precise control over the anaesthetic state.
2
Product and Dosage 1, 3, 4, 5 Ether for anaesthetic use is usually supplied in air-tight, amber-coloured, glass bottles. It is highly flammable, and there is a risk of explosion when mixed with oxygen or nitrous oxide (these risks not associated with halothane). Ether degenerates on exposure to light, heat and air and this is retarded by the addition of stabilisers. It should not be stored in polyvinyl chloride (PVC) bottles as it softens the PVC through which it can permeate. 6 Ether anaesthesia is administered in various ways, ranging from 'open ether' methods using a simple Schimmelbusch type mask, through simple draw-over vaporisers, to more expensive temperature and flow-compensated vaporisers such as the Epstein-Macintosh-Oxford (EMO) or Portable Anaesthesia Complete (PAC) type vaporisers. 7 For induction of anaesthesia the concentration in the inspired gas is up to 15%; for maintenance of light anaesthesia, the concentration in air is 3-5% (with or without muscle relaxants); for deep anaesthesia the concentration is up to 10%. Reduced inspired concentrations may suffice in elderly patients.
Unwanted effects
Ether irritates the respiratory mucosa -salivary and bronchial secretion are stimulated and laryngospasm may occur. These effects are concentration-dependent. Induction therefore may be slow and difficult. Recovery from prolonged anaesthesia is slow and the incidence of postoperative nausea and vomiting is high. Ether can cause potentially fatal convulsions. This is most likely in febrile children with sepsis given atropine and when the ambient temperature is high. Ether causes vasodilation that may lead to a substantial fall in blood pressure and reduce renal blood flow. However, renal failure has not been reported. Ether can prolong prothrombin time and increase capillary bleeding. It can raise the intracranial pressure, especially in a spontaneously breathing patient. Unlike halothane, ether is not regarded as hepatotoxic. However, occasional cases of fatty liver and other degenerative hepatic changes have been reported.
Because ether is both inflammable and explosive it is potentially dangerous to the patient and the operation theatre personnel alike. Sources of ignition include surgical diathermy, static electricity and sparks from defective switches or equipment.
Dependence on ether and ether vapour has been reported. It is subject to international control under the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances (1988).
Contraindications
The relative contraindications to the use of ether include:
Operating theatres where diathermy is in use or where the atmosphere cannot be made free from possible sources of ignition. Fever, especially in children. Raised intracranial pressure. Severe systemic disease affecting the heart, lungs, kidneys or liver.
Ether should be used with particular precaution:
In patients with diabetes, as ether can further increase blood sugar concentrations.
In women who are pregnant, as ether crosses the placenta and can depress neonatal respiration. At high altitudes, because above 2000 m its boiling point is lowered.
Evidence of value
The advantages of ether are that: 8 It is relatively cheap, and costs less than halothane (and the other volatile inhalational anaesthetics currently in use).
In the concentrations normally used, it stimulates respiration and circulation and thereby encourages its own absorption. Therefore, in a fit patient it may be used with air as the carrier gas, whereas oxygen is required for halothane (and most other volatile agents). It has good muscle relaxant property so that even major surgery may be undertaken without the use, or with minimum use, of a neuromuscular blocker. It has a relatively wide therapeutic index and is the safest for use in relatively inexperienced hands. 9, 10 Some of the disadvantages of ether can be minimised with attention to technique and detail. Induction can be made less troublesome with prior use of halothane, or an intravenous agent like thiopental and intubation under succinylcholine blockade. Although flammable, explosions rarely occur with ether because of the caution normally exercised in its use.
Recommendation
Ether is an effective inhalational general anaesthetic, but its many disadvantages make it less suitable than halothane in most settings. However, ether should continue to be listed in the WHO Model List of Essential Medicines because of its low cost and relative safety in inexperienced hands. It has a particular place in patients in whom halothane is contraindicated. We recommend that the WHO Model Formulary mentions that halothane (or possibly one of the newer fluorinated agents like isoflurane or sevoflurane) should be used in preference to ether where cost, training, equipment and patient susceptibilities permit.
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